All stocks · CHCL
CH

Cian Healthcare Limited

CHCL BSE Drug Manufacturers - Specialty & Generic Healthcare

Cian Healthcare Limited engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India. It offers pharmaceutical products in various therapeutic areas of gynecology, haematini…

ISIN INE05BN01027
Listed —
Quarters tracked —
Filings 15 docs

About

Cian Healthcare Limited engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India. It offers pharmaceutical products in various therapeutic areas of gynecology, haematinic, cardio- diabetic, orthopedic, pediatric, dermacosmetic, antibiotic, CNS, and vitamins and nutrient products. The company also provides male and female infertility, reproductive wellness, energy boosting, autism, multivitamins, joint care products, and haematinic products, as well as face and hair serums, veterinary products, and cosmetics. It offers its products in the form of tablets, capsules, soft gels, liquid orals, ointments/ creams and sachets, and cosmetics. The company exports its products to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, Sri Lanka, and Myanmar. The company was incorporated in 2003 and is based in Pune, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in — check back soon.

Profit & Loss

Annual · Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 28.0031.0059.0068.0064.0072.0057.0062.0066.0052.0047.0031.00
Expenses 35.0034.0051.0058.0059.0063.0049.0055.0053.0042.0039.0026.00
Operating Profit -6.00-3.008.009.005.0010.008.008.0013.0010.008.005.00
OPM % -23.00-9.0013.0013.008.0013.0014.0013.0020.0020.0016.0016.00
Other Income -12.00-12.001.001.000.000.001.001.000.000.000.000.00
Interest 0.002.005.005.005.006.006.006.006.005.004.001.00
Depreciation 2.003.004.004.003.002.002.002.002.002.002.001.00
Profit before tax -21.00-20.000.001.00-2.001.000.001.005.003.002.003.00
Tax % 1.000.00-3,800.0010.00-4.0051.00188.0031.0024.0025.0029.0032.00
Net Profit -21.00-20.000.001.00-2.000.000.001.004.002.002.002.00
EPS in Rs -8.41-7.870.160.43-0.910.14-0.030.38285.71165.00110.71186.00
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual · Rs. Crores — latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 25.0025.0025.0025.0025.0023.0023.0017.001.001.001.001.00
Reserves -4.0017.0037.0036.0035.0037.0036.005.0016.0012.0010.007.00
Borrowings 14.0040.0041.0043.0043.0049.0051.0049.0050.0040.0031.0032.00
Other Liabilities 14.0061.0040.0036.0036.0025.0024.0022.008.008.0015.006.00
Total Liabilities 48.00143.00143.00141.00140.00135.00135.0092.0077.0061.0057.0046.00
Fixed Assets 22.0023.0026.0029.0033.0019.0021.0023.0020.0021.0018.0019.00
CWIP 6.0015.0015.0014.0013.0026.0025.006.007.004.005.005.00
Investments 2.007.007.007.007.007.007.000.000.000.000.000.00
Other Assets 18.0097.0095.0090.0087.0083.0082.0062.0050.0036.0033.0022.00
Total Assets 48.00143.00143.00141.00140.00135.00135.0092.0077.0061.0057.0046.00

Cash Flows

Annual · Rs. Crores — latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 20.0021.007.002.006.005.00-9.0013.008.006.0010.000.00
Cash from Investing Activity 13.000.00-1.00-1.00-4.00-1.00-25.00-8.00-3.00-4.00-5.000.00
Cash from Financing Activity -50.00-3.00-6.00-1.00-3.00-5.0035.00-3.00-6.00-2.00-5.000.00
Net Cash Flow -17.0017.000.000.00-1.00-1.001.002.000.000.000.000.00
Free Cash Flow 29.0020.006.001.002.004.00-35.007.005.003.009.000.00
CFO/OP % -318.00-710.0092.0024.00109.0057.00-120.00162.0060.0063.00138.000.00

Ratios

Annual · Days / % — latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 118.00184.00114.00127.00104.0093.00128.00130.00142.0097.0095.00116.00
Inventory Days 74.00461.00404.00310.00325.00219.00214.00144.00160.00128.00137.00159.00
Days Payable 64.00609.00270.00211.00275.00151.00174.00144.0053.0021.00122.0071.00
Cash Conversion Cycle 128.0035.00248.00227.00154.00162.00168.00130.00249.00204.00111.00204.00
Working Capital Days 80.00-571.0049.0049.0061.0012.005.0044.0056.0040.0017.0052.00
ROCE % -13.00-6.005.006.003.007.007.009.0018.0017.0015.0014.00

Shareholding Pattern

% holding — latest first
Holder Mar 2026 Sep 2025 Mar 2025 Sep 2024 Jun 2024 Mar 2024 Sep 2023 Mar 2023 Dec 2022 Sep 2022 Mar 2022 Dec 2021
Promoters 95.00 27.11 27.11 27.11 27.10 27.10 49.62 51.85 66.26 66.26 66.26 66.26
DIIs 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.79 0.00 0.00 0.00
Public 5.00 72.89 72.89 72.90 72.90 72.90 50.39 48.16 32.96 33.75 33.74 33.74
No. of Shareholders 1,683 1,662 1,501 1,088 831 880 672 454 418 424 392 396

Corporate Actions

1 records
ActionEx DateRecord DateRatioAmount (₹)Notes
Other 21 Jan 2026 21 Jan 2026 — — Resolution Plan -Suspension

Announcements

5 filings

Shareholding Pattern

Open on BSE

Financial Results — Filings

Open on BSE

Board Filings

Open on BSE

Annual Reports

Credit Ratings

Back to all stocks